台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    44.25
  • 漲跌
    ▼0.05
  • 漲幅
    -0.11%
  • 成交量
    59
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-統一-敦南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-敦南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/0600.00544.3144.25-5190-2.63%
2025/01/22542.3000.0042.3052282.19%
2025/01/10043.49244.0043.35-2387-0.51%
2025/01/08242.5000.0042.7023840.52%
2024/12/30043.7900.0043.0004180.00%
2024/12/25042.7500.0042.6004410.01%
2024/12/24042.9500.0042.5504500.00%
2024/12/18043.0000.0042.3005150.00%
2024/12/06044.20244.2544.15-2611-0.33%
2024/12/02045.5000.0045.4006340.00%
2024/11/13047.7700.0047.2007190.00%
2024/11/11048.8200.0048.3507310.00%
2024/11/06049.7500.0049.3507460.00%
2024/11/05049.6000.0049.6007550.00%
2024/10/30051.5000.0050.5007770.00%
2024/10/281155.091053.1852.6017560.13%
2024/10/25154.4000.0054.4016450.15%
2024/10/11049.2900.0048.9501,0630.00%
2024/10/09051.0000.0049.1501,0590.00%
2024/10/07052.1000.0052.1001,0520.00%
2024/10/04052.5000.0052.4001,0520.00%
2024/10/01054.2000.0054.2001,0470.00%
2024/09/3000.000.154.8754.40-0.11,046-0.01%
2024/09/26052.0000.0051.9001,0230.00%
2024/09/23055.0000.0054.6001,0190.00%
2024/09/20054.0000.0055.0001,0230.00%
2024/09/19055.20556.1053.20-5995-0.50%
2024/09/1300.00248.2047.80-2967-0.21%
2024/09/12247.1500.0047.3029790.20%
2024/09/02550.5000.0050.7051,0030.50%
2024/08/30050.1000.0051.3009990.00%
2024/08/26049.70149.9549.65-1971-0.10%
2024/08/2300.00149.2049.35-1966-0.10%
2024/08/22150.2000.0049.8019620.10%
2024/08/21151.30150.6050.6009480.00%
2024/08/20151.00151.4050.9009430.00%
2024/08/15547.40549.8249.6009170.00%
2024/08/09048.9500.0048.1508790.00%
2024/08/08549.78249.8049.7538650.35%
2024/08/07350.70350.0050.7008560.00%
2024/08/06049.0500.0049.0008410.00%
2024/07/22056.3000.0056.2007520.00%
2024/07/19059.4000.0058.1007350.00%
2024/07/1800.002862.3262.20-28658-4.25%
2024/07/171558.771658.0458.90-1543-0.18%
2024/07/16156.00156.3057.2004270.00%
2024/07/03445.3900.0045.0043081.30%
2024/07/0200.00545.6245.50-5307-1.63%
2024/07/01247.3000.0047.1023020.66%
2024/06/27047.7000.0047.1002960.00%
2024/06/2400.00146.1545.50-1262-0.38%
2024/06/18245.18144.8044.0012130.47%
2024/06/1700.00245.2545.35-2187-1.07%
2024/06/13141.5000.0041.4511530.65%
2024/06/1100.00142.9042.60-1151-0.66%
2024/05/28041.9000.0042.3001640.00%
2024/05/24141.3500.0041.4511700.59%
2024/05/1700.00142.2042.45-1177-0.56%
2024/05/16142.10142.6041.7001770.00%
2024/05/06241.7000.0041.7521811.10%
2024/05/031042.2000.0041.75101825.49%
2024/04/22140.6500.0040.6511870.53%
2024/04/1500.00242.3542.30-2187-1.06%
2024/03/26344.2000.0043.0532021.48%
2024/03/210.142.8500.0042.700.12000.05%
2024/03/20341.3000.0041.5531981.51%
2024/03/1500.00342.8842.90-3200-1.50%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音